In the past year, numerous overseas companies have accelerated their entry into China through investment and affiliation. Recently, Neuro Health Sciences (Europe) has entered into a strategic partnership with Neuromins, and the two companies have established a joint venture in China to work together on brain science nutrition research. The Chinese R&D headquarters is located in the Guangdong Free Trade Zone Biomedical Industrial Park, covering an area of more than 2,000 square meters, and will further strengthen the globalization strategy by relying on the convenient import and export advantages of this national free-trade zone. A new medical product named NeuroiQ, the first innovative brain science pharmaceutical product in this strategic partnership, will be launched here for late-stage clinical trials. (Source: finance.ifeng)

Comments are closed.